PAFAHPlatelet Activating Factor Acetylhydrolase
References in periodicals archive ?
PAF is deacetylated to LysoPAF by PAFAH, a unique group of [PLA.
2] PNPLA1 Ichthyosis PNPLA2 Chanarin-Dorfman syndrome (neutral lipid strage disease with myopathy) PNPLA3 Non-alchoholic fatty liver disease (NASH, NAFLD) PNPLA6 Ataxia, Hereditary spastic paraplegia, Boucher-Neuhauser and Gordon Holmes syndromes Photoreceptor degeneration PNPLA7 Psychophysiological endophenotype PNPLA8 Myopathy PNPLA9/ PLA2G6 Parkinson's disease, Infantile neuroaxonal dystrophy (INAD) Familial melanoma PAFAH PAFAH/PLA2G7A Cardiovascular disease ABHD ABHD5 Chanarin-Dorfman Syndrome with ichtyosis ABHD12 PHARC syndrome (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract) s[PLA.
first reported that the deficiency of plasma PAFAH activity, one of the factors playing a role in the pathogenesis of CAD, was transmitted by autosomal recessive heredity in five Japanese families (17).